Knockdown of Hspa9, a del(5q31.2) gene, results in a decrease in hematopoietic progenitors in mice.

Area of Science:

• Hematology
• Molecular Biology
• Genetics

Background:

• Chromosome 5q31.2 deletions are common in myelodysplastic syndromes (MDS) and linked to acute myeloid leukemia (AML) progression with p53 mutations.
• Hspa9 was identified as a candidate gene within the 5q31.2 deletion region potentially involved in MDS and AML pathogenesis.

Purpose of the Study:

• To investigate if Hspa9 haploinsufficiency causes ineffective hematopoiesis characteristic of MDS.
• To analyze the role of Hspa9 in erythroid precursor maturation and hematopoietic stem cell function.

Main Methods:

• Hspa9 expression was reduced using lentiviral gene silencing in primary human hematopoietic cells.
• A murine bone marrow transplantation model was employed to study Hspa9 knockdown effects in vivo.
• Hematopoietic progenitor populations and cell cycle dynamics were assessed in knockdown models.

Main Results:

• Hspa9 knockdown in human cells delayed erythroid precursor maturation, suppressed cell growth, increased apoptosis, and reduced cell cycling.
• Reduced erythroid precursors, B lymphocytes, and key bone marrow progenitors (KLS, MEP) were observed in the murine Hspa9-knockdown model.
• Hspa9 haploinsufficiency was shown to alter the hematopoietic progenitor pool and contribute to abnormal hematopoiesis.

Conclusions:

• Hspa9 haploinsufficiency disrupts normal hematopoiesis, particularly affecting erythroid development and hematopoietic stem cell populations.
• The findings suggest that additional cooperating gene mutations are likely required for del(5q31.2) MDS cells to achieve clonal dominance.
• Hspa9 plays a significant role in maintaining hematopoietic progenitor pool homeostasis and normal blood cell formation.